You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

N-1 Perfusion

N-1 perfusion refers to the use of a cell retention device to achieve high cell density in the seed train step before the production bioreactor (N), achieving a more rapid and robust process while maintaining an existing Fed-Batch based production scheme.  

N-1 perfusion

A form of seed train intensification, N-1 perfusion refers to the intensification of cell growth in the step prior to the production bioreactor (N). This process intensification is done by attaching a cell retention device to the N-1 bioreactor to attain high cell density and viability. This seeds the production bioreactor at a higher starting cell density and shortens the production bioreactor run time. This can dramatically increase the facility output without direct change to the core production process.  A robust cell retention device is required to attain a high cell density inoculum for the production bioreactor.

Benefits of N-1 perfusion include:

  • Increased Fed-Batch process efficiency
  • Time and cost savings
  • Reduced operational risk
  • Smaller bioreactor footprint

N-1 perfusion can help optimize Fed-batch production in two ways:

High cell density seeding of the production bioreactor (N)
with the cell retention device attached to the N-1 bioreactor

Removal of the N-1 bioreactor
with the cell retention device attached to the N-2 bioreactor, if the N-2 bioreactor can provide enough cells for the production bioreactor (N)

Advances in n-1 perfusion

Alternating Tangential Flow (ATF) Filtration

An award-winning technology, ATF allows the removal of spent media while keeping cells in culture.  Applied using an XCell™ ATF device attached to a bioreactor, ATF minimizes cell shear and keeps cells in constant equilibrium with bioreactor contents. This results in faster cell growth at higher densities with higher productivity.  Today, the XCell™ ATF device, in single-use or reusable format, is the leading perfusion device for mAb and rProtein production.

Integrated Tangential Flow Filtration (TFF) Systems

Turnkey, easy-to-use, cost-effective and scalable hollow fiber systems for tangential flow filtration (TFF), single-use filter modules and state-of-the-art hollow fiber membranes enable process and cost efficiencies in upstream perfusion. KrosFlo® KML 100 and KPS TFF Systems are fully integrated and ready to use out of the box, the systems include precise and reproducible control and documentation of all TFF processes.

Single-use custom flow paths 

Ready-to-use connectivity between any bioreactor and the cell retention device facilitates the adoption of perfusion technologies.  Defined through an engineering design process, Pro-Connex® Flow Paths are customized, configurable and complete assemblies for tangential flow filtration. The assemblies are sterile and manufactured in compliance with ISO guidelines in an ISO 7 clean room.

Pro-Connex® Flow Paths

Potent cell culture supplements

Repligen developed and manufactures cell culture supplements that provide the benefits of serum supplementation while maintaining an animal-free process.

  • LONG®R3 IGF-I (LONG R3) is 200 times more potent and two times more stable in cell culture than insulin
  • LONG® EGF is a like-for-like replacement for native EGF or recombinant human EGF (hEGF)

CELL CULTURE SUPPLEMENTS

Resources

Expand All

Filtration Primer - WIP

How Alternating Tangential Flow (ATF) works - WIP

How Tangential Flow Filtration (TFF) works - WIP

XCell ATF from Repligen - WIP